Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vadim Ptushkin"'
Publikováno v:
Hematology Reports, Vol 15, Iss 3, Pp 503-512 (2023)
COVID-19 and other infectious diseases can exacerbate the course of paroxysmal nocturnal hemoglobinuria (PNH). The efficacy and safety of the Gam-COVID-Vac vaccine in patients with PNH has not been adequately studied. A retrospective, observational,
Externí odkaz:
https://doaj.org/article/f49c08b821c74431a6c611dee01c53bf
Autor:
Eugene Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova, Julia Sveshnikova, Galina Vyscub, Irina Matveeva, Maria Shirokova, Anna Shipaeva, Tatyana Klitochenko, Polina Makarovskaya, Elena Dmitrieva, Bella Biderman, Andrei Sudarikov, Tatyana Obukhova, Olga Samoilova, Kamil Kaplanov, Tatyana Konstantinova, Olga Mayorova, Irina Poddubnaya, Vadim Ptushkin
Publikováno v:
Leukemia.
Autor:
Eugene Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova, Julia Sveshnikova, Galina Vyscub, Irina Matveeva, Maria Shirokova, Anna Shipaeva, Tatyana Klitochenko, Elena Dmitrieva, Bella Biderman, Andrey Sudarikov, Tatyana Obukhova, Olga Samoilova, Kamil Kaplanov, Tatyana Konstantinova, Olga Mayorova, Irina Poddubnaya, Vadim Ptushkin
Autoimmune hemolytic anemia (AIHA) and pure red cell aplasia (PRCA) are common complications of CLL. The optimal treatment of steroid refractory AIHA/PRCA is not well established. We conducted a multicenter study of ibrutinib and rituximab in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c2f81fc7bc88f9f15f9b0161b9bbc46
https://doi.org/10.21203/rs.3.rs-2309221/v1
https://doi.org/10.21203/rs.3.rs-2309221/v1
Autor:
T S Konstantinova, Vladimir I. Vorobyev, Dmitry V. Motorin, Vladislav O. Sarzhevsky, Irina V. Poddubnaya, E A Baryakh, K. D. Kaplanov, Nikolay V. Zhukov, Vadim Ptushkin, Gayane Tumyan, E. A. Demina
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 52-55 (2020)
Relevance. COVID-19 pandemic currently has a significant negative impact on the treatment of patients with oncological pathology, including patients with classic Hodgkin lymphoma. Generalized data on publications on the impact of concomitant patholog
Autor:
Lori Shafner, Lori Volles, Flore Sicre de Fontbrune, Rasha Aguzzi, Viviani Pessoa, Anita J. Hill, Hubert Schrezenmeier, Lily Wong Lee Lee, Vadim Ptushkin, Rajendra Pradhan, Sandra Fátima Menosi Gualandro, Jong Wook Lee, Scott T. Rottinghaus, Wolfgang Füreder
Publikováno v:
Blood. 133:530-539
Ravulizumab (ALXN1210), a new complement C5 inhibitor, provides immediate, complete, and sustained C5 inhibition. This phase 3, open-label study assessed the noninferiority of ravulizumab to eculizumab in complement inhibitor–naive adults with paro
Autor:
Pavel A Zharkov, Dmitry M. Polokhov, Elena V. Suntsova, Vadim Ptushkin, Evgeniy A. Nikitin, Anna Shcherbina, Anastasia E Rudneva, Mikhail A. Panteleev, Anastasia A. Ignatova, Evgeniya A Ponomarenko, Ekaterina N Balashova, Daria V Fedorova, Alexei Maschan, Galina Novichkova
Publikováno v:
Platelets. 30:428-437
The ability of platelets to carry out their hemostatic function can be impaired in a wide range of inherited and acquired conditions: trauma, surgery, inflammation, pre-term birth, sepsis, hematological malignancies, solid tumors, chemotherapy, autoi
Autor:
Vadim Ptushkin, Aleksey Maschan, Vladimir I. Vorobyev, Dmitry M. Polokhov, Eugene Nikitin, Elena A. Dmitrieva, Aleksandr V. Poletaev, Kirill Voronin, Anastasia A. Ignatova, Galina Novichkova, Mikhail A. Panteleev, Elena A. Seregina
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(10)
Background Therapy with irreversible Bruton's tyrosine kinase inhibitor ibrutinib in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is associated with bleeding. Objectives To propose the predictive markers of such bleeding, as well
Autor:
Andrey Zaritskey, Boris A Rebrov, Janina Makarova, Averyan Vasylyev, Orest Tsyapka, Raigul Ramazanova, Evgeny D. Pashanov, Valentina Molostvova, Yuriy Popovych, Vadim Ptushkin
Publikováno v:
Cancer Management and Research
Averyan Vasylyev,1 Valentina Molostvova,2 Boris A Rebrov,3 Janina Makarova,4 Andrey Zaritskey,5 Vadim Ptushkin,6 Raigul Ramazanova,7 Yuriy Popovych,8 Orest Tsyapka,9 Evgeny Pashanov10 1CIS Medical, GlaxoSmithKline, Kiev, Ukraine; 2Regional Clinical H
Autor:
Igor I. Kireev, Olga Strelkova, Anastasia A. Ignatova, Elena A. Seregina, Sergei Ivanovich Obydennyi, Irina A. Demina, S. G. Khaspekova, Alexei V. Mazurov, Olga N Shustova, Mikhail A. Panteleev, Fazoil I. Ataullakhanov, Vadim Ptushkin, Dmitry M. Polokhov, Aleksandr A. Ryabykh, Maria M. Pankrashkina, Aleksandr V. Poletaev, Galina Novichkova, Alexei Maschan
Publikováno v:
British Journal of Haematology. 187
Autor:
L.W. Lee Lee, Lori Volles, Lori Shafner, F. Sicre de Fontbrune, Vadim Ptushkin, Scott T. Rottinghaus, Viviani Pessoa, Rajendra Pradhan, Anita J. Hill, Sandra Fátima Menosi Gualandro, Andrew I. Damokosh, Jong Wook Lee, Hubert Schrezenmeier, Wolfgang Füreder, Rasha Aguzzi, S. Ortis
Publikováno v:
Science meets clinical practice.